Dhakshayani Regenerative Medicine Preloader

Healing Today • Renewing Tomorrow

Therapeutic Portfolio

Regenerative Medicine & Organ Restoration Systems.

Harnessing biological systems, stem cells, tissue engineering, and DNA auto-correction to repair and replace damaged human tissues and failing organs.

Explore Tech Pipeline
Core Offerings

From Cellular Precision to Functional Organ Renewal

Dhakshayani integrates cutting-edge regenerative techniques to move beyond temporary symptomatic relief toward authentic biological restoration.

Organ Regeneration System
Primary Focus: Organ Restoration

1. Organ Regeneration Platforms

Repairing & Replacing Damaged or Lost Tissues & Organs

Organ regeneration applies complex biological systems to induce de novo healing in vital human tissues. By deploying autologous and allogeneic cellular matrices, our protocols trigger endogenous regenerative cascades to replace fibrotic or necrotic organ tissue with healthy, functionally active cells.

Hepatic & Renal Scaffolds: Targeted cell seeding for parenchymal tissue regeneration.
Cardiac & Vascular Renewal: Bio-compatible vascular graft regeneration and myocyte revitalization.
Neuro-Regenerative Pathways: Supporting synaptic and axonal renewal in neuro-degenerative phenotypes.
Pipeline: Pre-Clinical & Translational
Regenerative Medicine Products
Biologics & Bio-Formulations

2. Regenerative Medicine Products

Cellular Formulations, Substrates & Bio-Active Reagents

We formulate clinical-grade biological products manufactured under cleanroom conditions. These include proprietary extracellular vesicle preparations, regenerative growth factor secretomes, and standardized cellular culture substrates that support tissue self-renewal.

Bio-Active Secretomes: Lyophilized paracrine signaling factors for accelerated wound repair.
Extracellular Matrix Gels: Injectable biomimetic hydrogels that facilitate cellular homing.
Cell Culture Preservatives: High-fidelity cryopreservation media for stem cell viability.
ISO 15189 Aligned Production
Stem Cell DNA Auto-Correction
Proprietary: DNA Auto-Correction

3. Stem Cell Therapies via DNA Auto-Correction

High-Fidelity Genomic Restoration for Regenerative Delivery

Prior to therapeutic delivery, cultured stem cells often accumulate replication errors or inherit patient-specific deleterious genetic variants. Our proprietary DNA Auto Correction workflow integrates bioinformatic guided mismatch repair and enzymatic proofreading to ensure stem cells possess maximum regenerative potency without oncogenic risk.

Mesenchymal Stem Cells (MSCs): Bone-marrow, umbilical cord, and adipose-derived lineages.
Epigenetic Stability Assays: Comprehensive profiling to verify telomere integrity and chromosomal stability.
Zero Viral Vector Integration: Non-integrating enzymatic correction techniques for utmost patient safety.
QC: ACMG 5-Tier Benchmarked View Tech Details
Tissue Engineering 3D Bio-Printing
Structural Bio-Systems

4. Tissue Engineering & 3D Bio-Scaffolding

Biomimetic Scaffolds & Vascularized Tissue Constructs

Combining advanced biocompatible polymers with patient-derived cell populations, our tissue engineering division develops structured 3D constructs that replicate natural organ architecture. These scaffolds degrade naturally as newly seeded cells deposit endogenous extracellular matrix.

Osteochondral Tissue Constructs: Complex multi-phasic matrices for joint and cartilage renewal.
Skin & Dermal Replacements: Full-thickness living biological bandages for severe burns and chronic ulcers.
Microvascular Pre-Patterning: Microfluidic channels ensuring adequate oxygenation across thick tissue grafts.
Incubated at VFSTR TBI
Supporting Diagnostics

Next-Generation Sequencing & Precision Testing

Accurate diagnosis precedes effective regeneration. Our laboratory offers clinical-grade genomic assays analyzed under strict ACMG guidelines.

TAT: 14-18 Days

Whole Exome Sequencing (WES)

Comprehensive interrogation of ~20,000 coding genes for pediatric dysmorphology and unexplained rare disease phenotypes.

Depth: 100X
TAT: 5-7 Days

Non-Invasive Prenatal (NIPT)

Cell-free maternal plasma screen for fetal aneuploidies (Trisomy 21, 18, 13) and microdeletion syndromes with >99.7% sensitivity.

Fetal Fraction >4%
TAT: 10-12 Days

Hereditary Oncology Panels

Multi-gene panels (BRCA1/2, Lynch Syndrome, TP53) identifying familial predisposition and targeted therapy biomarkers.

NCCN Aligned
TAT: 24-48 Hours

Board Genetic Counseling

Pre-test and post-test consultations conducted in English, Telugu, and Hindi by board-certified clinical genetic counselors.

Tele-Consult / On-Site
Clinical Partnerships

Partner with Dhakshayani for Hospital & Lab Integration

We partner with multi-specialty hospitals, research institutes, and IVF centers across Andhra Pradesh and India. Get turnkey cold-chain specimen pickup and direct access to our laboratory consultants.